Lv1
15 积分 2021-07-28 加入
Current landscape of CD3 bispecific antibodies in hematologic malignancies
25天前
已完结
A Review of Recent FDA-Approved Biologic-Device Combination Products
25天前
已完结
BCMA-directed therapy for early relapsed and/or refractory multiple myeloma
26天前
已完结
Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins
26天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
26天前
已完结
CAR T cells produced in vivo to treat cardiac injury
1个月前
已完结
Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee
1个月前
已完结
细胞因子释放综合征的发病机制及诊断分级与处理方案
1个月前
已完结
Mechanisms of resistance against T-cell engaging bispecific antibodies in multiple myeloma: implications for novel treatment strategies
1个月前
已完结
皖公网安备34019202002308
